Posted by Michael Wonder on 10 Nov 2021
Health Canada authorises the use of the Pfizer-BioNTech Comirnaty COVID-19 vaccine as a booster shot
9 November 2021 - Health Canada has authorized the use of the Pfizer-BioNTech Comirnaty COVID-19 vaccine as a booster shot.
Health Canada received Pfizer's submission to approve a booster on 1 October 2021. After a thorough, independent review of the evidence, Health Canada has determined that the Comirnaty COVID-19 vaccine booster shot meets the Department's stringent safety, efficacy and quality requirements.
The booster is authorised for adults 18 years of age and older, to be used at least six months after an individual has completed their primary vaccine series. The Comirnaty COVID-19 booster is a full dose of the regular vaccine (30 mcg).
